Suppr超能文献

经皮基因递送至静脉导管在完全性心脏阻滞猪模型中创建的生物起搏器。

Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block.

机构信息

Cedars-Sinai Heart Institute, Los Angeles, California 90048, USA.

出版信息

Heart Rhythm. 2012 Aug;9(8):1310-8. doi: 10.1016/j.hrthm.2012.04.020. Epub 2012 Apr 20.

Abstract

BACKGROUND

Pacemaker-dependent patients with device infection require temporary pacing while the infection is treated. External transthoracic pacing is painful and variably effective, while temporary pacing leads are susceptible to superinfection.

OBJECTIVE

To create a biological pacemaker delivered via venous catheters in a porcine model of complete heart block, providing a temporary alternative/adjunct to external pacing devices without additional indwelling hardware.

METHODS

Complete atrioventricular (AV) nodal block was induced in pigs by radiofrequency ablation after the implantation of a single-chamber electronic pacemaker to maintain a ventricular backup rate of 50 beats/min. An adenoviral vector cocktail (K(AAA) + H2), expressing dominant-negative inward rectifier potassium channel (Kir2.1AAA) and hyperpolarization-activated cation channel (HCN2) genes, was injected into the AV junctional region via a NOGA Myostar catheter advanced through the femoral vein.

RESULTS

Animals injected with K(AAA) + H2 maintained a physiologically relevant ventricular rate of 93.5 ± 7 beats/min (n = 4) compared with control animals (average rate, 59.4 ± 4 beats/min; n = 6 at day 7 postinjection; P <.05). Backup electronic pacemaker utilization decreased by almost 4-fold in the K(AAA) + H2 group compared with the control (P <.05), an effect maintained for the entire 14-day window. In contrast to the efficacy of gene delivery into the AV junctional region, open-chest, direct injection of K(AAA) + H2 (or its individual vectors) into the ventricular myocardium failed to elicit significant pacemaker activity.

CONCLUSIONS

The right-sided delivery of K(AAA) + H2 to the AV junctional region provided physiologically relevant biological pacing over a 14-day period. Our approach may provide temporary, bridge-to-device pacing for the effective clearance of infection prior to the reimplantation of a definitive electronic pacemaker.

摘要

背景

依赖起搏器的感染患者在治疗感染时需要临时起搏。体外经胸起搏既痛苦又效果不一,而临时起搏导线易发生继发感染。

目的

在完全性心脏阻滞的猪模型中,通过静脉导管输送生物起搏器,为体外起搏设备提供临时替代/辅助治疗,而无需留置额外的硬件。

方法

在植入单腔电子起搏器以维持 50 次/分的心室备用率后,通过射频消融术在猪体内诱导完全房室(AV)结阻滞。通过经股静脉推进的 NOGA Myostar 导管将表达显性失活内向整流钾通道(Kir2.1AAA)和超极化激活阳离子通道(HCN2)基因的腺病毒载体鸡尾酒(K(AAA)+ H2)注射到 AV 结区。

结果

与对照组动物(注射后 7 天平均心率 59.4 ± 4 次/分;n = 6)相比,注射 K(AAA)+ H2 的动物维持了与生理相关的心室率 93.5 ± 7 次/分(n = 4;P <.05)。与对照组相比,K(AAA)+ H2 组的备用电子起搏器使用率降低了近 4 倍(P <.05),这种效果持续了整个 14 天的观察期。与 AV 结区基因传递的疗效相反,直接向心室心肌注射 K(AAA)+ H2(或其单个载体)无法引起明显的起搏器活动。

结论

将 K(AAA)+ H2 右侧输送到 AV 结区在 14 天内提供了与生理相关的生物起搏。我们的方法可以在重新植入永久性电子起搏器之前,为有效清除感染提供临时、桥接设备起搏。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验